文章盘点了剑桥地区21家风险投资机构，介绍其关注领域与投资方向，涵盖从SR One的生命科学到F-Prime的科技与医疗健康等代表性机构。
Finding the right investor in Cambridge can feel like a big task, but the local scene is full of strong partners. Firms like F-Prime have been around since 1946, with nearly 100 exits, showing the long-term potential here.
It's not just about longevity; firms like Flagship Pioneering have made over 280 investments, while SR One has seen more than 60 exits. To help you find the right fit, we've focused on the investors we think are most worth your time.
Below is our list of the best 21 VC firms in Cambridge.
Failory's Top 10 Picks
Tool
Fundraising OS
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Safar Partners provides seed- to growth-stage funding for technology companies emerging from research universities like MIT, Harvard, and the University of Rochester. They concentrate on platform technologies in fields including cleantech, advanced materials, AI, robotics, and life sciences.
Year Founded2019 FoundersArunas Chesonis, Nader Motamedy Investment StageEarly Stage, Late Stage, SeedNº of Investments76 (15 as Lead Investor) Nº of Exits6 Contactinfo@safar.partners / (646) 510-4833Castle Island Ventures invests exclusively in early-stage companies building the infrastructure and applications for public blockchains. The firm's mission is to help these foundational technologies scale and power services for a massive global user base.
Year Founded2018 FoundersMatt Walsh, Nic Carter Investment StageEarly StageNº of Investments115 (36 as Lead Investor) Nº of Exits8 Contact617-401-4017First Star Ventures partners with technical founders at the seed and early stages, funding companies that use data and machine learning to solve real-world problems. They concentrate on frontier technologies such as AI and computational biotech, drawing on an extensive network of strategic partners to help their startups grow quickly.
Year Founded2014 FoundersDrew Volpe, Millie Liu Investment StageEarly Stage, SeedNº of Investments58 (9 as Lead Investor) Nº of Exits9 Contactcontact@firststar.vc / (707) 733-3739As the corporate venture capital arm of GlaxoSmithKline, SR One invests globally in emerging life science companies. The firm seeks out businesses with innovative science that can significantly impact medical care, providing funding across all stages from seed to post-IPO.
Year Founded1985 Founders— Investment StageEarly Stage, Late Stage, Post-Ipo, Private Equity, SeedNº of Investments206 (66 as Lead Investor) Nº of Exits66 (38 IPO'd) Contact(610) 567-1000Flagship Pioneering originates and develops companies based on scientific breakthroughs to transform human health and sustainability. Rather than simply investing, the firm acts as a company-creation platform, systematically building new ventures from bold scientific propositions.
Year Founded2000 FoundersEdwin Kania, Noubar Afeyan, Thomas de Vlaam Investment StageDebt, Early Stage, Late Stage, Post-Ipo, Private EquityNº of Investments285 (102 as Lead Investor) Nº of Exits70 (33 IPO'd) Contact617-868-1888Amadeus Capital Partners invests globally in technology companies across sectors like enterprise software, medtech, and cleantech. They support entrepreneurs at every stage from seed to buyout, offering operational experience and the flexibility of purchasing stakes from existing investors.
Year Founded1997 FoundersAnne Glover, Hermann Hauser Investment StageEarly Stage, Late Stage, Private Equity, SeedNº of Investments285 (83 as Lead Investor) Nº of Exits62 (7 IPO'd) Contactinfo@amadeuscapital.com / +44 3330 024 0777Link Ventures funds early-stage, direct-to-consumer internet companies poised for hyper-growth. Their proprietary, data-driven approach to sourcing investments has helped build a portfolio that includes companies like EverQuote.
Year Founded2006 FoundersDavid Blundin, Robert Chaplinsky Investment StageConvertible Note, Debt, Early Stage, Late Stage, SeedNº of Investments54 (21 as Lead Investor) Nº of Exits5 (1 IPO'd) Contactlinkventures@linkventures.com / (781) 228-5674Mission BioCapital invests in early-stage life science companies, providing the capital and guidance needed to launch. The firm is distinguished by its leadership team, which draws on a long history of building science-based businesses to offer deep expertise and support.
Year Founded2009 FoundersJohannes Fruehauf, Johannes Fruehauf, Peter Parker Investment StageEarly Stage, Late Stage, SeedNº of Investments80 (15 as Lead Investor) Nº of Exits19 (8 IPO'd) Contacthello@missionbiocapital.com / +1 617-812-3350Cambridge Innovation Capital backs life sciences and deep-tech companies with a strong connection to the Cambridge ecosystem. As a preferred investor for the University of Cambridge, they gain unparalleled access to disruptive businesses across sectors like AI, quantum technologies, and genomics.
Year Founded2013 FoundersWilliam Tunstall-Pedoe Investment StageEarly Stage, Late Stage, SeedNº of Investments93 (32 as Lead Investor) Nº of Exits11 (1 IPO'd) Contactenquiries@cic.vc / +44 (0) 1223 764875With a history of backing iconic companies like Atari and Alibaba, F-Prime Capital Partners invests in technology and life sciences startups from their earliest stages. Because the firm doesn't raise outside capital, its global teams can focus entirely on supporting entrepreneurs as they build their companies.
Year Founded1946 Founders— Total Funding$30MIndustriesEnterprise, Fintech, HealthcareInvestment StageEarly Stage, Late Stage, SeedNº of Investments507 (124 as Lead Investor) Nº of Exits98 (47 IPO'd) Top Portfolio StartupsSironax, Teleo, StageContactinfo@fprimecapital.com / 617-231-240011 Additional Cambridge VC Firms Worth Pitching
Of course, our top picks aren't the only VCs worth knowing in town. The firms below have backed over 1,400 startups and celebrated more than 300 exits combined.
They're writing checks for companies in biotech, climate, and software, reflecting the city's diverse talent. Take a look at the other venture capital firms helping build what's next in Cambridge.